News

Filter by Category

Filter by Program

Filter by Publish Date

C-Path’s Role in IHI Call 4: Enhancing Rare Disease Clinical Trials

This memo outlines how C-Path can contribute as a key strategic regulatory partner to the Innovative Health Initiative’s (I

C-Path is proud to welcome ObvioHealth, a virtual research organization (VRO), as the newest member of its Electro

C-Path’s PRO Consortium and eCOA Consortium are pleased to announce the publication of an open access article in the Value

July 20, 2023

C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in Transplantation by William Fit

May 31, 2023

C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in the American Journal of Transplan

C-Path is proud to welcome Red Nucleus Clinical as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consor

The Critical Path Institute’s CURE Drug Repurposing Collaboratory and FDA hosted their annual meeting April 18-20 to bring toget

C-Path’s Rare Disease COA Consortium is pleased to announce that “Approaches to the Assessment of Clinical Benefit of Treatmen

March 29, 2023

Critical Path Institute (C-Path) announced today the appointment of three accomplished leaders to key executive roles within the..

March 15, 2023